A detailed history of Bell Investment Advisors, Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Bell Investment Advisors, Inc holds 2,069 shares of ABBV stock, worth $378,482. This represents 0.08% of its overall portfolio holdings.

Number of Shares
2,069
Previous 2,063 0.29%
Holding current value
$378,482
Previous $353,000 15.58%
% of portfolio
0.08%
Previous 0.07%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.84 - $199.33 $983 - $1,195
6 Added 0.29%
2,069 $408,000
Q2 2024

Aug 07, 2024

SELL
$154.79 - $180.76 $154 - $180
-1 Reduced 0.05%
2,063 $353,000
Q1 2024

May 08, 2024

BUY
$159.82 - $182.1 $5,274 - $6,009
33 Added 1.62%
2,064 $375,000
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $17,337 - $19,526
126 Added 6.61%
2,031 $314,000
Q3 2023

Nov 08, 2023

BUY
$133.59 - $154.65 $165,918 - $192,075
1,242 Added 187.33%
1,905 $283,000
Q2 2023

Aug 09, 2023

SELL
$132.51 - $164.9 $31,139 - $38,751
-235 Reduced 26.17%
663 $89,000
Q1 2023

May 10, 2023

BUY
$144.61 - $166.54 $10,556 - $12,157
73 Added 8.85%
898 $143,000
Q4 2022

Feb 08, 2023

BUY
$138.31 - $165.87 $20,469 - $24,548
148 Added 21.86%
825 $133,000
Q3 2022

Nov 09, 2022

BUY
$134.21 - $153.93 $11,005 - $12,622
82 Added 13.78%
677 $91,000
Q2 2022

Aug 12, 2022

BUY
$137.62 - $174.96 $3,853 - $4,898
28 Added 4.94%
595 $91,000
Q4 2021

Feb 14, 2022

BUY
$107.43 - $135.93 $18,263 - $23,108
170 Added 42.82%
567 $77,000
Q3 2021

Nov 12, 2021

BUY
$106.4 - $120.78 $42,240 - $47,949
397 New
397 $43,000

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $323B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Bell Investment Advisors, Inc Portfolio

Follow Bell Investment Advisors, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bell Investment Advisors, Inc, based on Form 13F filings with the SEC.

News

Stay updated on Bell Investment Advisors, Inc with notifications on news.